Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting



Current orthotopic xenograft models of human colorectal cancer (CRC) require surgery and do not robustly form metastases in the liver, the most common site clinically. CCR9 traffics lymphocytes to intestine and colorectum. We engineered use of the chemokine receptor CCR9 in CRC cell lines and patient-derived cells to create primary gastrointestinal (GI) tumors in immunodeficient mice by tail-vein injection rather than surgery. The tumors metastasize inducibly and robustly to the liver. Metastases have higher DKK4 and NOTCH signaling levels and are more chemoresistant than paired subcutaneous xenografts. Using this approach, we generated 17 chemokine-targeted mouse models (CTMMs) that recapitulate the majority of common human somatic CRC mutations. We also show that primary tumors can be modeled in immunocompetent mice by microinjecting CCR9-expressing cancer cell lines into early-stage mouse blastocysts, which induces central immune tolerance. We expect that CTMMs will facilitate investigation of the biology of CRC metastasis and drug screening.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Modeling primary human CRC recurrent mutations in mice without survival surgery.
Figure 2: Human primary CRC-immunoproficient mouse host chimeras.
Figure 3: Sequential human CRC primary GI tumor-metastasis formation.
Figure 4: Increased chemoresistance of human CRC cells in liver versus orthotopic or subcutaneous xenografts.

Accession codes

Primary accessions

Sequence Read Archive


  1. Ellis, L.M. Preclinical data targeting vascular endothelial growth factor in colorectal cancer. Clin. Colorectal Cancer 4 (suppl. 2), S55–S61 (2004).

    Article  CAS  Google Scholar 

  2. Siolas, D. & Hannon, G.J. Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res. 73, 5315–5319 (2013).

    Article  CAS  Google Scholar 

  3. Sikandar, S.S. et al. NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res. 70, 1469–1478 (2010).

    Article  CAS  Google Scholar 

  4. Kabelitz, D. & Wesch, D. Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors. Crit. Rev. Immunol. 23, 339–370 (2003).

    Article  CAS  Google Scholar 

  5. Youn, B.S., Kim, Y.J., Mantel, C., Yu, K.Y. & Broxmeyer, H.E. Blocking of c-FLIP(L)–independent cycloheximide-induced apoptosis or Fas-mediated apoptosis by the CC chemokine receptor 9/TECK interaction. Blood 98, 925–933 (2001).

    Article  CAS  Google Scholar 

  6. Li, X. et al. Deconvoluting the intestine: molecular evidence for a major role of the mesenchyme in the modulation of signaling cross talk. Physiol. Genomics 29, 290–301 (2007).

    Article  CAS  Google Scholar 

  7. Chen, H.J. et al. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis. J. Clin. Invest. 122, 3184–3196 (2012).

    Article  CAS  Google Scholar 

  8. Ebert, M.P. et al. TFAP2E–DKK4 and chemoresistance in colorectal cancer. N. Engl. J. Med. 366, 44–53 (2012).

    Article  CAS  Google Scholar 

  9. Meng, R.D. et al. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res. 69, 573–582 (2009).

    Article  CAS  Google Scholar 

  10. He, K., Zhao, H., Wang, Q. & Pan, Y. A comparative genome analysis of gene expression reveals different regulatory mechanisms between mouse and human embryo pre-implantation development. Reproductive biology and endocrinology. Reprod. Biol. Endocrinol. 8, 41 (2010).

    Article  Google Scholar 

  11. Maekawa, M. et al. Requirement of the MAP kinase signaling pathways for mouse preimplantation development. Development 132, 1773–1783 (2005).

    Article  CAS  Google Scholar 

  12. Bleul, C.C. & Boehm, T. Chemokines define distinct microenvironments in the developing thymus. Eur. J. Immunol. 30, 3371–3379 (2000).

    Article  CAS  Google Scholar 

  13. Schneider, J.S.V.J., Terzic, A. & Fraidenraich, D. Blastocyst injection of embryonic stem cells: a simple approach to unveil mechanisms of corrections in mouse models of human disease. Stem Cell Rev. 5, 369–377 (2009).

    Article  Google Scholar 

  14. Eds Johan Auwerx, S.L.A. et al. Current Protocols in Mouse Biology (Wiley, 2013).

  15. Meurens, F. et al. Expression of mucosal chemokines TECK/CCL25 and MEC/CCL28 during fetal development of the ovine mucosal immune system. Immunology 120, 544–555 (2007).

    Article  CAS  Google Scholar 

  16. Meurens, F. et al. Expression of TECK/CCL25 and MEC/CCL28 chemokines and their respective receptors CCR9 and CCR10 in porcine mucosal tissues. Vet. Immunol. Immunopathol. 113, 313–327 (2006).

    Article  CAS  Google Scholar 

  17. Lautt, W.W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am. J. Physiol. 249, G549–G556 (1985).

    CAS  PubMed  Google Scholar 

  18. Thiel, H. Liver hemodynamics and portacaval shunt. Surg. Gynecol. Obstet. 150, 587–592 (1980).

    CAS  PubMed  Google Scholar 

  19. Walters, S. et al. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int. J. Cancer 132, 676–685 (2013).

    Article  CAS  Google Scholar 

  20. Dancis, J. Transport of substances across perfused organs. Acta Endocrinol. Suppl. (Copenh.) 158, 347–375 (1972).

    Article  CAS  Google Scholar 

  21. Okumura, K. et al. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer. Oncol. Rep. 15, 875–882 (2006).

    CAS  PubMed  Google Scholar 

  22. Jahid, S. et al. miR-23a promotes the transition from indolent to invasive colorectal cancer. Cancer Discov. 2, 540–553 (2012).

    Article  CAS  Google Scholar 

  23. Yu, C.R., Peden, K.W., Zaitseva, M.B., Golding, H. & Farber, J.M. CCR9A and CCR9B: two receptors for the chemokine CCL25/TECK/Ck beta-15 that differ in their sensitivities to ligand. J. Immunol. 164, 1293–1305 (2000).

    Article  CAS  Google Scholar 

  24. Wagner, M. et al. Effective treatment of advanced colorectal cancer by rapamycin and 5-FU/oxaliplatin monitored by TIMP-1. J. Gastrointest. Surg. 13, 1781–1790 (2009).

    Article  Google Scholar 

  25. Nagy, A. Manipulating the Mouse Embryo: A Laboratory Manual, 3rd Edn. (Cold Spring Harbor Laboratory Press, 2003).

  26. Chen, C., Khaleel, S.S., Huang, H. & Wu, C.H. Software for pre-processing Illumina next-generation sequencing short read sequences. Source Code Biol. Med. doi:10.1186/1751-0473-9-8 (3 May 2014).

  27. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).

    Article  CAS  Google Scholar 

  28. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).

    Article  CAS  Google Scholar 

  29. Cao, Z. et al. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell 25, 350–365 (2014).

    Article  CAS  Google Scholar 

Download references


We thank other members of the Lipkin laboratory and Shen Laboratory for helpful discussions. We also thank the Cornell BRC imaging and Stem Cell and Transgenic Core Facilities. This work was supported by the National Science Foundation (NSF) 1137269, NSF 1106153, NSF GRFP-2011131053, National Institutes of Health (NIH) R01 GM095990, CA098626, NIH 2UL1-RR024996, NIH UH2TR000516, Defense Advanced Research Projects Agency 19-1091726, and generous donations by Matthew Bell and Fred Greenberg.

Author information

Authors and Affiliations



H.J.C., X.S. and S.M.L. proposed the concept, designed the experiments and co-wrote the manuscript; H.J.C., Z.H., M.A., N.R., Joyce Chen, P.B., L.W., Y.X., Jonlin Chen and M.S. performed the experiments; J.S., K.Y.C. and Z.H.G. contributed to bioinformatics analyses; H.H.J., R.M., C.A. and W.E. performed blastocyst injections; N.R., D.J.J., Jiahn Choi, P.G. and N.N. performed multiphoton imaging; J.M. and G.N. provided tissue samples; R.L. performed assays for detecting immune cells; X.K.Z. performed statistical analysis; R.E. and A.D.M. performed histopathology analyses.

Corresponding authors

Correspondence to Xiling Shen or Steven M Lipkin.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–12, Supplementary Tables 1–3, Supplementary Methods (PDF 14691 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chen, H., Sun, J., Huang, Z. et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol 33, 656–660 (2015).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer